On November 16, 2009
Will Plavix Competitor Cangrelor Be a Prince Rather than a Frog for The Medicines Co.?
The Medicines Co., which six months ago stopped two likely-to-fail Phase III trials of antiplatelet drug cangrelor, is out to prove its frog of a drug may be a prince after all.
0 Comments